Experimental Study to Validate the Modified Glucose Disposal Test

Completed · Phase 1

Conditions studied: Diabetes

In brief

Evaluate the modified GDT as a measure of key metabolic characteristics in healthy subjects and those with type 2 diabetes mellitus

Key facts

Study ID

NCT01152372

Run by

Bristol-Myers Squibb

People needed

36

Starts

2010-06-01

Expected to finish

2010-11-01

Last updated by the study team

2011-02-23

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of Type 2 diabetes
• Clinically healthy
• Drug naive or on a stable dose of metformin monotherapy and/or a secretagogue

You may not qualify if…

• Type 1 Diabetes
• History of significant heart disease.
• Bariatric surgery
• Exposure to fibrates, thiazolidinediones, insulin, exenatide, pramlintide or DPP-IV inhibitors

Where it is running

• Profil Institute For Clinical Research, Inc. (Picr) — Chula Vista, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.